MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term investments$904,558K Cash and cashequivalents$51,828K Accounts receivable, net$35,000K Prepaid expenses andother current assets$10,663K Total property andequipment$10,898K Total current assets$1,002,049K Operating leaseright-of-use assets$17,870K Other long-termassets$3,944K Property and equipment,net$3,546K Restricted cash$816K Less accumulateddepreciation$7,352K Total assets$1,028,225K Total liabilities andstockholders' equity$1,028,225K Total stockholders'equity$941,535K Total liabilities$86,690K Accumulated deficit-$375,743K Additional paid-in capital$1,316,642K Total currentliabilities$58,915K Operating leaseliabilities, net of current...$19,099K Deferred revenue, net ofcurrent portion$8,676K Accumulated othercomprehensive income$576K Common stock, 0.001 parvalue authorized...$60K Current portion ofdeferred revenue$37,591K Accrued expenses$15,476K Accounts payable$3,376K Current portion ofoperating lease...$2,472K
Balance Sheet

Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. (JANX)

source: myfinsight.com